annual CFI:
-$126.80M+$340.30M(+72.85%)Summary
- As of today (May 29, 2025), NBIX annual cash flow from investing activities is -$126.80 million, with the most recent change of +$340.30 million (+72.85%) on December 31, 2024.
- During the last 3 years, NBIX annual CFI has risen by +$3.40 million (+2.61%).
- NBIX annual CFI is now -205.42% below its all-time high of $120.28 million, reached on December 31, 2006.
Performance
NBIX Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$14.20M+$82.50M(+120.79%)Summary
- As of today (May 29, 2025), NBIX quarterly cash flow from investing activities is $14.20 million, with the most recent change of +$82.50 million (+120.79%) on March 31, 2025.
- Over the past year, NBIX quarterly CFI has increased by +$69.20 million (+125.82%).
- NBIX quarterly CFI is now -84.80% below its all-time high of $93.40 million, reached on June 30, 2020.
Performance
NBIX quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$57.60M+$69.20M(+54.57%)Summary
- As of today (May 29, 2025), NBIX TTM cash flow from investing activities is -$57.60 million, with the most recent change of +$69.20 million (+54.57%) on March 31, 2025.
- Over the past year, NBIX TTM CFI has increased by +$422.40 million (+88.00%).
- NBIX TTM CFI is now -147.89% below its all-time high of $120.28 million, reached on December 31, 2006.
Performance
NBIX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
NBIX Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +72.8% | +125.8% | +88.0% |
| 3 y3 years | +2.6% | +144.9% | +74.4% |
| 5 y5 years | +39.9% | -57.2% | +73.7% |
NBIX Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +72.8% | -54.8% | +107.0% | -52.4% | +88.0% |
| 5 y | 5-year | -3192.7% | +72.8% | -84.8% | +107.0% | -269.4% | +88.0% |
| alltime | all time | -205.4% | +72.8% | -84.8% | +106.7% | -147.9% | +88.0% |
NBIX Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $14.20M(-120.8%) | -$57.60M(-54.6%) |
| Dec 2024 | -$126.80M(-72.9%) | -$68.30M(-376.5%) | -$126.80M(-51.3%) |
| Sep 2024 | - | $24.70M(-187.6%) | -$260.30M(-31.9%) |
| Jun 2024 | - | -$28.20M(-48.7%) | -$382.30M(-20.4%) |
| Mar 2024 | - | -$55.00M(-72.7%) | -$480.00M(+2.8%) |
| Dec 2023 | -$467.10M(+163.7%) | -$201.80M(+107.4%) | -$467.10M(+22.6%) |
| Sep 2023 | - | -$97.30M(-22.7%) | -$380.90M(+10.4%) |
| Jun 2023 | - | -$125.90M(+199.0%) | -$344.90M(+83.8%) |
| Mar 2023 | - | -$42.10M(-63.6%) | -$187.60M(+5.9%) |
| Dec 2022 | -$177.10M(+36.0%) | -$115.60M(+88.6%) | -$177.10M(+368.5%) |
| Sep 2022 | - | -$61.30M(-295.2%) | -$37.80M(-63.2%) |
| Jun 2022 | - | $31.40M(-199.4%) | -$102.70M(-54.3%) |
| Mar 2022 | - | -$31.60M(-233.3%) | -$224.90M(+72.7%) |
| Dec 2021 | -$130.20M(-3275.6%) | $23.70M(-118.8%) | -$130.20M(-56.8%) |
| Sep 2021 | - | -$126.20M(+39.0%) | -$301.60M(+100.8%) |
| Jun 2021 | - | -$90.80M(-243.9%) | -$150.20M(-541.8%) |
| Mar 2021 | - | $63.10M(-142.7%) | $34.00M(+729.3%) |
| Dec 2020 | $4.10M(-101.9%) | -$147.70M(-686.1%) | $4.10M(-128.5%) |
| Sep 2020 | - | $25.20M(-73.0%) | -$14.40M(-88.5%) |
| Jun 2020 | - | $93.40M(+181.3%) | -$125.20M(-42.8%) |
| Mar 2020 | - | $33.20M(-120.0%) | -$218.90M(+3.7%) |
| Dec 2019 | -$211.10M(-13.1%) | -$166.20M(+94.2%) | -$211.10M(+39.7%) |
| Sep 2019 | - | -$85.60M(>+9900.0%) | -$151.14M(+36.6%) |
| Jun 2019 | - | -$300.00K(-100.7%) | -$110.64M(-23.6%) |
| Mar 2019 | - | $41.00M(-138.6%) | -$144.85M(-40.4%) |
| Dec 2018 | -$242.90M(-3.3%) | -$106.24M(+135.6%) | -$242.90M(+23.9%) |
| Sep 2018 | - | -$45.09M(+30.7%) | -$196.05M(+5.2%) |
| Jun 2018 | - | -$34.51M(-39.5%) | -$186.35M(-49.0%) |
| Mar 2018 | - | -$57.05M(-3.9%) | -$365.15M(+45.3%) |
| Dec 2017 | -$251.25M(-322.4%) | -$59.39M(+67.8%) | -$251.25M(+42.2%) |
| Sep 2017 | - | -$35.39M(-83.4%) | -$176.70M(+80.1%) |
| Jun 2017 | - | -$213.31M(-475.2%) | -$98.11M(-198.6%) |
| Mar 2017 | - | $56.85M(+275.0%) | $99.55M(-11.9%) |
| Dec 2016 | $112.95M(-157.7%) | $15.16M(-64.9%) | $112.95M(-5.8%) |
| Sep 2016 | - | $43.20M(-375.9%) | $119.85M(+316.3%) |
| Jun 2016 | - | -$15.66M(-122.3%) | $28.79M(-404.2%) |
| Mar 2016 | - | $70.25M(+218.6%) | -$9.46M(-95.2%) |
| Dec 2015 | -$195.81M(+85.8%) | $22.05M(-146.1%) | -$195.81M(-3.2%) |
| Sep 2015 | - | -$47.86M(-11.2%) | -$202.32M(+33.8%) |
| Jun 2015 | - | -$53.91M(-53.6%) | -$151.25M(-2.9%) |
| Mar 2015 | - | -$116.09M(-846.8%) | -$155.73M(+47.8%) |
| Dec 2014 | -$105.37M(-2073.1%) | $15.54M(+383.4%) | -$105.37M(+5.2%) |
| Sep 2014 | - | $3.22M(-105.5%) | -$100.18M(-4.3%) |
| Jun 2014 | - | -$58.40M(-11.2%) | -$104.70M(+313.6%) |
| Mar 2014 | - | -$65.73M(-417.1%) | -$25.31M(-574.0%) |
| Dec 2013 | $5.34M(-115.4%) | $20.73M(-1688.4%) | $5.34M(-57.3%) |
| Sep 2013 | - | -$1.30M(-106.2%) | $12.50M(-48.9%) |
| Jun 2013 | - | $20.99M(-159.8%) | $24.46M(-199.3%) |
| Mar 2013 | - | -$35.08M(-225.8%) | -$24.62M(-29.2%) |
| Dec 2012 | -$34.76M(+884.2%) | $27.89M(+161.7%) | -$34.76M(-44.9%) |
| Sep 2012 | - | $10.65M(-137.9%) | -$63.10M(+12.9%) |
| Jun 2012 | - | -$28.09M(-37.9%) | -$55.89M(+102.4%) |
| Mar 2012 | - | -$45.22M(>+9900.0%) | -$27.61M(+681.8%) |
| Dec 2011 | -$3.53M(-93.5%) | -$451.00K(-102.5%) | -$3.53M(-83.9%) |
| Sep 2011 | - | $17.86M(+9154.4%) | -$21.93M(-62.7%) |
| Jun 2011 | - | $193.00K(-100.9%) | -$58.74M(-28.0%) |
| Mar 2011 | - | -$21.14M(+12.1%) | -$81.56M(+49.1%) |
| Dec 2010 | -$54.70M | -$18.85M(-0.5%) | -$54.70M(+83.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | -$18.95M(-16.2%) | -$29.77M(+888.0%) |
| Jun 2010 | - | -$22.63M(-495.3%) | -$3.01M(-114.9%) |
| Mar 2010 | - | $5.72M(-5.9%) | $20.19M(+67.5%) |
| Dec 2009 | $12.06M(-72.9%) | $6.09M(-22.0%) | $12.06M(+10.8%) |
| Sep 2009 | - | $7.80M(+1242.9%) | $10.88M(+72.5%) |
| Jun 2009 | - | $581.00K(-124.1%) | $6.31M(+16.7%) |
| Mar 2009 | - | -$2.41M(-149.1%) | $5.41M(-87.8%) |
| Dec 2008 | $44.42M(+113.2%) | $4.91M(+52.0%) | $44.42M(+34.9%) |
| Sep 2008 | - | $3.23M(-1109.1%) | $32.93M(-35.6%) |
| Jun 2008 | - | -$320.00K(-100.9%) | $51.14M(+16.4%) |
| Mar 2008 | - | $36.60M(-656.4%) | $43.95M(+110.9%) |
| Dec 2007 | $20.84M(-82.7%) | -$6.58M(-130.7%) | $20.84M(-58.8%) |
| Sep 2007 | - | $21.44M(-385.1%) | $50.58M(-6.1%) |
| Jun 2007 | - | -$7.52M(-155.7%) | $53.89M(-27.5%) |
| Mar 2007 | - | $13.49M(-41.7%) | $74.33M(-38.2%) |
| Dec 2006 | $120.28M(+1182.0%) | $23.16M(-6.4%) | $120.28M(+37.8%) |
| Sep 2006 | - | $24.75M(+91.5%) | $87.31M(+119.1%) |
| Jun 2006 | - | $12.93M(-78.3%) | $39.85M(-31.7%) |
| Mar 2006 | - | $59.44M(-706.4%) | $58.38M(+522.2%) |
| Dec 2005 | $9.38M(-49.2%) | -$9.80M(-56.8%) | $9.38M(-62.9%) |
| Sep 2005 | - | -$22.72M(-172.2%) | $25.31M(-76.1%) |
| Jun 2005 | - | $31.46M(+201.2%) | $105.70M(+24.7%) |
| Mar 2005 | - | $10.44M(+70.4%) | $84.74M(+358.8%) |
| Dec 2004 | $18.47M(-109.9%) | $6.13M(-89.4%) | $18.47M(-198.4%) |
| Sep 2004 | - | $57.67M(+449.6%) | -$18.77M(-89.0%) |
| Jun 2004 | - | $10.49M(-118.8%) | -$170.26M(-14.6%) |
| Mar 2004 | - | -$55.83M(+79.4%) | -$199.34M(+6.8%) |
| Dec 2003 | -$186.65M(+305.6%) | -$31.11M(-66.8%) | -$186.65M(+35.4%) |
| Sep 2003 | - | -$93.81M(+404.7%) | -$137.81M(+518.4%) |
| Jun 2003 | - | -$18.59M(-56.9%) | -$22.28M(-297.2%) |
| Mar 2003 | - | -$43.13M(-343.4%) | $11.30M(-124.6%) |
| Dec 2002 | -$46.02M(+176.6%) | $17.72M(-18.4%) | -$46.02M(-49.4%) |
| Sep 2002 | - | $21.72M(+44.8%) | -$90.89M(-27.1%) |
| Jun 2002 | - | $14.99M(-114.9%) | -$124.66M(-5.0%) |
| Mar 2002 | - | -$100.45M(+269.9%) | -$131.16M(+688.4%) |
| Dec 2001 | -$16.64M(-78.0%) | -$27.16M(+125.5%) | -$16.64M(-74.4%) |
| Sep 2001 | - | -$12.04M(-241.8%) | -$65.10M(+48.8%) |
| Jun 2001 | - | $8.49M(-39.6%) | -$43.75M(-17.6%) |
| Mar 2001 | - | $14.07M(-118.6%) | -$53.07M(-29.9%) |
| Dec 2000 | -$75.67M(+257.0%) | -$75.62M(-912.0%) | -$75.67M(+159.6%) |
| Sep 2000 | - | $9.31M(-1222.0%) | -$29.15M(-25.6%) |
| Jun 2000 | - | -$830.00K(-90.3%) | -$39.17M(+38.2%) |
| Mar 2000 | - | -$8.54M(-70.7%) | -$28.34M(+33.7%) |
| Dec 1999 | -$21.20M(-551.1%) | -$29.10M(+4057.1%) | -$21.20M(-643.6%) |
| Sep 1999 | - | -$700.00K(-107.0%) | $3.90M(-61.8%) |
| Jun 1999 | - | $10.00M(-814.3%) | $10.20M(-1233.3%) |
| Mar 1999 | - | -$1.40M(-65.0%) | -$900.00K(-119.1%) |
| Dec 1998 | $4.70M(-165.3%) | -$4.00M(-171.4%) | $4.70M(-622.2%) |
| Sep 1998 | - | $5.60M(-609.1%) | -$900.00K(-95.4%) |
| Jun 1998 | - | -$1.10M(-126.2%) | -$19.50M(-657.1%) |
| Mar 1998 | - | $4.20M(-143.8%) | $3.50M(-148.6%) |
| Dec 1997 | -$7.20M(-85.2%) | -$9.60M(-26.2%) | -$7.20M(+118.2%) |
| Sep 1997 | - | -$13.00M(-159.4%) | -$3.30M(-17.5%) |
| Jun 1997 | - | $21.90M(-436.9%) | -$4.00M(-91.4%) |
| Mar 1997 | - | -$6.50M(+14.0%) | -$46.60M(-4.1%) |
| Dec 1996 | -$48.60M | -$5.70M(-58.4%) | -$48.60M(+13.3%) |
| Sep 1996 | - | -$13.70M(-33.8%) | -$42.90M(+46.9%) |
| Jun 1996 | - | -$20.70M(+143.5%) | -$29.20M(+243.5%) |
| Mar 1996 | - | -$8.50M | -$8.50M |
FAQ
- What is Neurocrine Biosciences annual cash flow from investing activities?
- What is the all time high annual CFI for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual CFI year-on-year change?
- What is Neurocrine Biosciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly CFI year-on-year change?
- What is Neurocrine Biosciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for Neurocrine Biosciences?
- What is Neurocrine Biosciences TTM CFI year-on-year change?
What is Neurocrine Biosciences annual cash flow from investing activities?
The current annual CFI of NBIX is -$126.80M
What is the all time high annual CFI for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual cash flow from investing activities is $120.28M
What is Neurocrine Biosciences annual CFI year-on-year change?
Over the past year, NBIX annual cash flow from investing activities has changed by +$340.30M (+72.85%)
What is Neurocrine Biosciences quarterly cash flow from investing activities?
The current quarterly CFI of NBIX is $14.20M
What is the all time high quarterly CFI for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly cash flow from investing activities is $93.40M
What is Neurocrine Biosciences quarterly CFI year-on-year change?
Over the past year, NBIX quarterly cash flow from investing activities has changed by +$69.20M (+125.82%)
What is Neurocrine Biosciences TTM cash flow from investing activities?
The current TTM CFI of NBIX is -$57.60M
What is the all time high TTM CFI for Neurocrine Biosciences?
Neurocrine Biosciences all-time high TTM cash flow from investing activities is $120.28M
What is Neurocrine Biosciences TTM CFI year-on-year change?
Over the past year, NBIX TTM cash flow from investing activities has changed by +$422.40M (+88.00%)